An in silico clinical trial, also known as a virtual clinical trial, is an individualized computer simulation used in the development or regulatory evaluation of a medicinal product, device, or intervention. While completely simulated clinical trials are not feasible with current technology and understanding of biology, its development would be expected to have major benefits over current in vivo clinical trials, and research on it is being pursued.
This report aims to provide a comprehensive presentation of the global market for In Silico Clinical Trials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Silico Clinical Trials. This report contains market size and forecasts of In Silico Clinical Trials in global, including the following market information:
Global In Silico Clinical Trials Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global In Silico Clinical Trials market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Phase I Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of In Silico Clinical Trials include Certara, Inc., Novadiscovery Sas, Insilico Medicine, Inc., Dassault Systemes SE, GNS Healthcare Inc., The AnyLogic Company, InSilicoTrials, Immunetrics Inc. and Nuventra Pharma Sciences, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the In Silico Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global In Silico Clinical Trials Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global In Silico Clinical Trials Market Segment Percentages, by Type, 2022 (%)
Phase I
Phase II
Phase III
Phase IV
Global In Silico Clinical Trials Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global In Silico Clinical Trials Market Segment Percentages, by Application, 2022 (%)
Oncology
Infectious Disease
Hematology
Cardiology
Dermatology
Neurology
Diabetes
Others
Global In Silico Clinical Trials Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global In Silico Clinical Trials Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies In Silico Clinical Trials revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies In Silico Clinical Trials revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Certara, Inc.
Novadiscovery Sas
Insilico Medicine, Inc.
Dassault Systemes SE
GNS Healthcare Inc.
The AnyLogic Company
InSilicoTrials
Immunetrics Inc.
Nuventra Pharma Sciences
Abzena Ltd.
Siemens
Outline of Major Chapters:
Chapter 1: Introduces the definition of In Silico Clinical Trials, market overview.
Chapter 2: Global In Silico Clinical Trials market size in revenue.
Chapter 3: Detailed analysis of In Silico Clinical Trials company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of In Silico Clinical Trials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 In Silico Clinical Trials Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global In Silico Clinical Trials Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global In Silico Clinical Trials Overall Market Size
2.1 Global In Silico Clinical Trials Market Size: 2022 VS 2029
2.2 Global In Silico Clinical Trials Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top In Silico Clinical Trials Players in Global Market
3.2 Top Global In Silico Clinical Trials Companies Ranked by Revenue
3.3 Global In Silico Clinical Trials Revenue by Companies
3.4 Top 3 and Top 5 In Silico Clinical Trials Companies in Global Market, by Revenue in 2022
3.5 Global Companies In Silico Clinical Trials Product Type
3.6 Tier 1, Tier 2 and Tier 3 In Silico Clinical Trials Players in Global Market
3.6.1 List of Global Tier 1 In Silico Clinical Trials Companies
3.6.2 List of Global Tier 2 and Tier 3 In Silico Clinical Trials Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global In Silico Clinical Trials Market Size Markets, 2022 & 2029
4.1.2 Phase I
4.1.3 Phase II
4.1.4 Phase III
4.1.5 Phase IV
4.2 By Type - Global In Silico Clinical Trials Revenue & Forecasts
4.2.1 By Type - Global In Silico Clinical Trials Revenue, 2018-2023
4.2.2 By Type - Global In Silico Clinical Trials Revenue, 2024-2029
4.2.3 By Type - Global In Silico Clinical Trials Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global In Silico Clinical Trials Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Infectious Disease
5.1.4 Hematology
5.1.5 Cardiology
5.1.6 Dermatology
5.1.7 Neurology
5.1.8 Diabetes
5.1.9 Others
5.2 By Application - Global In Silico Clinical Trials Revenue & Forecasts
5.2.1 By Application - Global In Silico Clinical Trials Revenue, 2018-2023
5.2.2 By Application - Global In Silico Clinical Trials Revenue, 2024-2029
5.2.3 By Application - Global In Silico Clinical Trials Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global In Silico Clinical Trials Market Size, 2022 & 2029
6.2 By Region - Global In Silico Clinical Trials Revenue & Forecasts
6.2.1 By Region - Global In Silico Clinical Trials Revenue, 2018-2023
6.2.2 By Region - Global In Silico Clinical Trials Revenue, 2024-2029
6.2.3 By Region - Global In Silico Clinical Trials Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America In Silico Clinical Trials Revenue, 2018-2029
6.3.2 US In Silico Clinical Trials Market Size, 2018-2029
6.3.3 Canada In Silico Clinical Trials Market Size, 2018-2029
6.3.4 Mexico In Silico Clinical Trials Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe In Silico Clinical Trials Revenue, 2018-2029
6.4.2 Germany In Silico Clinical Trials Market Size, 2018-2029
6.4.3 France In Silico Clinical Trials Market Size, 2018-2029
6.4.4 U.K. In Silico Clinical Trials Market Size, 2018-2029
6.4.5 Italy In Silico Clinical Trials Market Size, 2018-2029
6.4.6 Russia In Silico Clinical Trials Market Size, 2018-2029
6.4.7 Nordic Countries In Silico Clinical Trials Market Size, 2018-2029
6.4.8 Benelux In Silico Clinical Trials Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia In Silico Clinical Trials Revenue, 2018-2029
6.5.2 China In Silico Clinical Trials Market Size, 2018-2029
6.5.3 Japan In Silico Clinical Trials Market Size, 2018-2029
6.5.4 South Korea In Silico Clinical Trials Market Size, 2018-2029
6.5.5 Southeast Asia In Silico Clinical Trials Market Size, 2018-2029
6.5.6 India In Silico Clinical Trials Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America In Silico Clinical Trials Revenue, 2018-2029
6.6.2 Brazil In Silico Clinical Trials Market Size, 2018-2029
6.6.3 Argentina In Silico Clinical Trials Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa In Silico Clinical Trials Revenue, 2018-2029
6.7.2 Turkey In Silico Clinical Trials Market Size, 2018-2029
6.7.3 Israel In Silico Clinical Trials Market Size, 2018-2029
6.7.4 Saudi Arabia In Silico Clinical Trials Market Size, 2018-2029
6.7.5 UAE In Silico Clinical Trials Market Size, 2018-2029
7 In Silico Clinical Trials Companies Profiles
7.1 Certara, Inc.
7.1.1 Certara, Inc. Company Summary
7.1.2 Certara, Inc. Business Overview
7.1.3 Certara, Inc. In Silico Clinical Trials Major Product Offerings
7.1.4 Certara, Inc. In Silico Clinical Trials Revenue in Global Market (2018-2023)
7.1.5 Certara, Inc. Key News & Latest Developments
7.2 Novadiscovery Sas
7.2.1 Novadiscovery Sas Company Summary
7.2.2 Novadiscovery Sas Business Overview
7.2.3 Novadiscovery Sas In Silico Clinical Trials Major Product Offerings
7.2.4 Novadiscovery Sas In Silico Clinical Trials Revenue in Global Market (2018-2023)
7.2.5 Novadiscovery Sas Key News & Latest Developments
7.3 Insilico Medicine, Inc.
7.3.1 Insilico Medicine, Inc. Company Summary
7.3.2 Insilico Medicine, Inc. Business Overview
7.3.3 Insilico Medicine, Inc. In Silico Clinical Trials Major Product Offerings
7.3.4 Insilico Medicine, Inc. In Silico Clinical Trials Revenue in Global Market (2018-2023)
7.3.5 Insilico Medicine, Inc. Key News & Latest Developments
7.4 Dassault Systemes SE
7.4.1 Dassault Systemes SE Company Summary
7.4.2 Dassault Systemes SE Business Overview
7.4.3 Dassault Systemes SE In Silico Clinical Trials Major Product Offerings
7.4.4 Dassault Systemes SE In Silico Clinical Trials Revenue in Global Market (2018-2023)
7.4.5 Dassault Systemes SE Key News & Latest Developments
7.5 GNS Healthcare Inc.
7.5.1 GNS Healthcare Inc. Company Summary
7.5.2 GNS Healthcare Inc. Business Overview
7.5.3 GNS Healthcare Inc. In Silico Clinical Trials Major Product Offerings
7.5.4 GNS Healthcare Inc. In Silico Clinical Trials Revenue in Global Market (2018-2023)
7.5.5 GNS Healthcare Inc. Key News & Latest Developments
7.6 The AnyLogic Company
7.6.1 The AnyLogic Company Company Summary
7.6.2 The AnyLogic Company Business Overview
7.6.3 The AnyLogic Company In Silico Clinical Trials Major Product Offerings
7.6.4 The AnyLogic Company In Silico Clinical Trials Revenue in Global Market (2018-2023)
7.6.5 The AnyLogic Company Key News & Latest Developments
7.7 InSilicoTrials
7.7.1 InSilicoTrials Company Summary
7.7.2 InSilicoTrials Business Overview
7.7.3 InSilicoTrials In Silico Clinical Trials Major Product Offerings
7.7.4 InSilicoTrials In Silico Clinical Trials Revenue in Global Market (2018-2023)
7.7.5 InSilicoTrials Key News & Latest Developments
7.8 Immunetrics Inc.
7.8.1 Immunetrics Inc. Company Summary
7.8.2 Immunetrics Inc. Business Overview
7.8.3 Immunetrics Inc. In Silico Clinical Trials Major Product Offerings
7.8.4 Immunetrics Inc. In Silico Clinical Trials Revenue in Global Market (2018-2023)
7.8.5 Immunetrics Inc. Key News & Latest Developments
7.9 Nuventra Pharma Sciences
7.9.1 Nuventra Pharma Sciences Company Summary
7.9.2 Nuventra Pharma Sciences Business Overview
7.9.3 Nuventra Pharma Sciences In Silico Clinical Trials Major Product Offerings
7.9.4 Nuventra Pharma Sciences In Silico Clinical Trials Revenue in Global Market (2018-2023)
7.9.5 Nuventra Pharma Sciences Key News & Latest Developments
7.10 Abzena Ltd.
7.10.1 Abzena Ltd. Company Summary
7.10.2 Abzena Ltd. Business Overview
7.10.3 Abzena Ltd. In Silico Clinical Trials Major Product Offerings
7.10.4 Abzena Ltd. In Silico Clinical Trials Revenue in Global Market (2018-2023)
7.10.5 Abzena Ltd. Key News & Latest Developments
7.11 Siemens
7.11.1 Siemens Company Summary
7.11.2 Siemens Business Overview
7.11.3 Siemens In Silico Clinical Trials Major Product Offerings
7.11.4 Siemens In Silico Clinical Trials Revenue in Global Market (2018-2023)
7.11.5 Siemens Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. In Silico Clinical Trials Market Opportunities & Trends in Global Market
Table 2. In Silico Clinical Trials Market Drivers in Global Market
Table 3. In Silico Clinical Trials Market Restraints in Global Market
Table 4. Key Players of In Silico Clinical Trials in Global Market
Table 5. Top In Silico Clinical Trials Players in Global Market, Ranking by Revenue (2022)
Table 6. Global In Silico Clinical Trials Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global In Silico Clinical Trials Revenue Share by Companies, 2018-2023
Table 8. Global Companies In Silico Clinical Trials Product Type
Table 9. List of Global Tier 1 In Silico Clinical Trials Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 In Silico Clinical Trials Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global In Silico Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - In Silico Clinical Trials Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - In Silico Clinical Trials Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global In Silico Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - In Silico Clinical Trials Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - In Silico Clinical Trials Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global In Silico Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global In Silico Clinical Trials Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global In Silico Clinical Trials Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America In Silico Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America In Silico Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe In Silico Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe In Silico Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia In Silico Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia In Silico Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America In Silico Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America In Silico Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa In Silico Clinical Trials Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa In Silico Clinical Trials Revenue, (US$, Mn), 2024-2029
Table 30. Certara, Inc. Company Summary
Table 31. Certara, Inc. In Silico Clinical Trials Product Offerings
Table 32. Certara, Inc. In Silico Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 33. Certara, Inc. Key News & Latest Developments
Table 34. Novadiscovery Sas Company Summary
Table 35. Novadiscovery Sas In Silico Clinical Trials Product Offerings
Table 36. Novadiscovery Sas In Silico Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 37. Novadiscovery Sas Key News & Latest Developments
Table 38. Insilico Medicine, Inc. Company Summary
Table 39. Insilico Medicine, Inc. In Silico Clinical Trials Product Offerings
Table 40. Insilico Medicine, Inc. In Silico Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 41. Insilico Medicine, Inc. Key News & Latest Developments
Table 42. Dassault Systemes SE Company Summary
Table 43. Dassault Systemes SE In Silico Clinical Trials Product Offerings
Table 44. Dassault Systemes SE In Silico Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 45. Dassault Systemes SE Key News & Latest Developments
Table 46. GNS Healthcare Inc. Company Summary
Table 47. GNS Healthcare Inc. In Silico Clinical Trials Product Offerings
Table 48. GNS Healthcare Inc. In Silico Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 49. GNS Healthcare Inc. Key News & Latest Developments
Table 50. The AnyLogic Company Company Summary
Table 51. The AnyLogic Company In Silico Clinical Trials Product Offerings
Table 52. The AnyLogic Company In Silico Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 53. The AnyLogic Company Key News & Latest Developments
Table 54. InSilicoTrials Company Summary
Table 55. InSilicoTrials In Silico Clinical Trials Product Offerings
Table 56. InSilicoTrials In Silico Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 57. InSilicoTrials Key News & Latest Developments
Table 58. Immunetrics Inc. Company Summary
Table 59. Immunetrics Inc. In Silico Clinical Trials Product Offerings
Table 60. Immunetrics Inc. In Silico Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 61. Immunetrics Inc. Key News & Latest Developments
Table 62. Nuventra Pharma Sciences Company Summary
Table 63. Nuventra Pharma Sciences In Silico Clinical Trials Product Offerings
Table 64. Nuventra Pharma Sciences In Silico Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 65. Nuventra Pharma Sciences Key News & Latest Developments
Table 66. Abzena Ltd. Company Summary
Table 67. Abzena Ltd. In Silico Clinical Trials Product Offerings
Table 68. Abzena Ltd. In Silico Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 69. Abzena Ltd. Key News & Latest Developments
Table 70. Siemens Company Summary
Table 71. Siemens In Silico Clinical Trials Product Offerings
Table 72. Siemens In Silico Clinical Trials Revenue (US$, Mn) & (2018-2023)
Table 73. Siemens Key News & Latest Developments
List of Figures
Figure 1. In Silico Clinical Trials Segment by Type in 2022
Figure 2. In Silico Clinical Trials Segment by Application in 2022
Figure 3. Global In Silico Clinical Trials Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global In Silico Clinical Trials Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global In Silico Clinical Trials Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by In Silico Clinical Trials Revenue in 2022
Figure 8. By Type - Global In Silico Clinical Trials Revenue Market Share, 2018-2029
Figure 9. By Application - Global In Silico Clinical Trials Revenue Market Share, 2018-2029
Figure 10. By Type - Global In Silico Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global In Silico Clinical Trials Revenue Market Share, 2018-2029
Figure 12. By Application - Global In Silico Clinical Trials Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global In Silico Clinical Trials Revenue Market Share, 2018-2029
Figure 14. By Region - Global In Silico Clinical Trials Revenue Market Share, 2018-2029
Figure 15. By Country - North America In Silico Clinical Trials Revenue Market Share, 2018-2029
Figure 16. US In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 17. Canada In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe In Silico Clinical Trials Revenue Market Share, 2018-2029
Figure 20. Germany In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 21. France In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 23. Italy In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 24. Russia In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia In Silico Clinical Trials Revenue Market Share, 2018-2029
Figure 28. China In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 29. Japan In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 32. India In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America In Silico Clinical Trials Revenue Market Share, 2018-2029
Figure 34. Brazil In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa In Silico Clinical Trials Revenue Market Share, 2018-2029
Figure 37. Turkey In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 38. Israel In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 40. UAE In Silico Clinical Trials Revenue, (US$, Mn), 2018-2029
Figure 41. Certara, Inc. In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novadiscovery Sas In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Insilico Medicine, Inc. In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Dassault Systemes SE In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GNS Healthcare Inc. In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. The AnyLogic Company In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. InSilicoTrials In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Immunetrics Inc. In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Nuventra Pharma Sciences In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Abzena Ltd. In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Siemens In Silico Clinical Trials Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
